COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 169 filers reported holding COHERUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,865,000 | +1.6% | 498,599 | +16.0% | 0.00% | 0.0% |
| Q2 2023 | $1,836,000 | -37.6% | 430,000 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $2,941,000 | -13.7% | 430,000 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $3,406,000 | -17.8% | 430,000 | -0.1% | 0.00% | -20.0% |
| Q3 2022 | $4,145,000 | +32.7% | 430,591 | -0.2% | 0.01% | +25.0% |
| Q2 2022 | $3,123,000 | -43.9% | 431,375 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $5,569,000 | -19.1% | 431,375 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $6,885,000 | -0.7% | 431,375 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $6,932,000 | +16.2% | 431,375 | 0.0% | 0.01% | +20.0% |
| Q2 2021 | $5,966,000 | -5.3% | 431,375 | 0.0% | 0.01% | -44.4% |
| Q1 2021 | $6,302,000 | -16.0% | 431,375 | -0.1% | 0.01% | -18.2% |
| Q4 2020 | $7,503,000 | -5.2% | 431,746 | 0.0% | 0.01% | -15.4% |
| Q3 2020 | $7,918,000 | +2.7% | 431,746 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $7,711,000 | +10.6% | 431,746 | +0.4% | 0.01% | -7.1% |
| Q1 2020 | $6,975,000 | -9.9% | 430,000 | 0.0% | 0.01% | +27.3% |
| Q4 2019 | $7,742,000 | -11.1% | 430,000 | 0.0% | 0.01% | -26.7% |
| Q3 2019 | $8,712,000 | -69.4% | 430,000 | -66.7% | 0.02% | -6.2% |
| Q2 2019 | $28,509,000 | +386.1% | 1,290,000 | +200.0% | 0.02% | +60.0% |
| Q1 2019 | $5,865,000 | +50.6% | 430,000 | -0.1% | 0.01% | +25.0% |
| Q4 2018 | $3,895,000 | -45.1% | 430,300 | 0.0% | 0.01% | -33.3% |
| Q3 2018 | $7,100,000 | +17.1% | 430,300 | -0.6% | 0.01% | +20.0% |
| Q2 2018 | $6,062,000 | +30.6% | 433,000 | +3.1% | 0.01% | +25.0% |
| Q1 2018 | $4,641,000 | +33.1% | 420,000 | +6.0% | 0.01% | +33.3% |
| Q4 2017 | $3,487,000 | -9.9% | 396,300 | +36.7% | 0.01% | -14.3% |
| Q3 2017 | $3,872,000 | -13.2% | 290,000 | -6.7% | 0.01% | -12.5% |
| Q2 2017 | $4,462,000 | +341.8% | 310,923 | +551.1% | 0.01% | +300.0% |
| Q1 2017 | $1,010,000 | -15.7% | 47,755 | +12.2% | 0.00% | 0.0% |
| Q4 2016 | $1,198,000 | -23.2% | 42,555 | -27.0% | 0.00% | -33.3% |
| Q3 2016 | $1,560,000 | -16.8% | 58,255 | -47.6% | 0.00% | +50.0% |
| Q2 2016 | $1,876,000 | – | 111,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |